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Early treatment with isoflurane improves cardiac
function and increases survival in a rat model of
TAKO-TSUBO cardiomyopathy
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Introduction
Tako-tsubo cardiomyopathy (TCM) is an acute cardiac
syndrome with severe hypokinesia of the left ventricle
(LV), often affecting the apex causing apical ballooning
and heart failure. Sympathetic stress is a trigger of TCM
and is probably underdiagnosed and not uncommon in
ICU patients [1]. We have developed an experimental
rat model of TCM, in which LV apical akinesia develops
after intraperitoneal (i.p.) injection of isoprenaline with
many similarities to clinical TCM [2]. We recently
demonstrated that pre-treatment with isoflurane could
prevent the development of LV apical akinesia in this
TCM animal model [3].
Objectives
In the present study, we examined whether isoflurane,
when used for treatment, could attenuate the degree of
LV dysfunction and reduce mortality in a TCM animal
model.
Methods
TCM was induced in seventy-five propofol sedated animals
by intraperitonial injection of isoprenaline (50 mg/kg).
Within 90 minutes after injection, the animals develop
tako-tsubo-like heart failure with apical dyskinesia/akinesia
and reduced cardiac output [2]. The animals were rando-
mized to either inhalation with no isoflurane (CONTROL,
n=15) or inhalation with 1% isoflurane before (ISOFL 0,
n=15), 10 min (ISOFL 10, n=15), 30 min (ISOFL 30, n=15)
and 120 min (ISOFL 120, n=15) after induction of TCM.
Evaluation of cardiac function with echocardiography was
performed 90 minutes after isoprenaline in all animals.
Extent of apical akinesia was expressed as percentage of
LV endocardial length that was akinetic. After the experi-
mental procedure, the animals were monitored for
48 hours for assessment of survival.
Results
Early institution of treatment with isoflurane, attenuated
the degree of LV dysfunction after isoprenaline injection,
as the degree of akinesia was lower in ISOFL 0, ISOFL
10, ISOFL 30 compared to CONTROL (Figure 1).
48 hours survival was higher in ISOFL 0, ISOFL 10,
ISOFL 30 versus CONTROL, while there was no differ-
ence in 48 hours survival between ISOFL 120 and
CONTROL (Figure 2). In a multivariable model, isoflur-
ane inhalation within 30 minutes (ISOFL 0, ISOFL 10,
ISOFL 30), was an independent predictor of 48 hour
survival.
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Conclusions
In this animal model of TCM, isoflurane treatment, when
started early after induction of TCM, highly attenuated
degree of LV apical akinesia. This was accompanied by a
clearly improvement of survival. Isoflurane sedation in
the ICU could be a beneficial strategy in patients suffer-
ing from hyper-adrenergic conditions.
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